The Board of Directors of Sumitomo Chemical India Limited met on January 27, 2026, to approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. For the quarter ended December 31, 2025 (Q3 FY26), the company reported a consolidated revenue of ₹5,679.78 million, representing an 11.5% decrease from ₹6,419.19 million in the corresponding quarter of the previous year (YoY) and a significant decline from the previous quarter’s performance. Consolidated net profit for Q3 FY26 stood at ₹758.00 million, a 13.3% drop from ₹874.30 million in Q3 FY25. On a standalone basis, revenue fell 11.4% YoY to ₹5,517.58 million, while net profit declined 11.2% YoY to ₹748.26 million. Despite the quarterly dip, the nine-month performance remained resilient with a 7.2% growth in standalone net profit reaching ₹4,325.29 million.

Sumitomo Chemical India Limited is a leading player in the Indian crop protection industry, offering a balanced portfolio of technical and formulation products. The company operates in various segments including agro-chemicals, environmental health, and animal nutrition. In late 2025, the company integrated its domestic polyolefin business (PP and LLDPE) into Prime Polymer and reached an agreement to acquire a Taiwanese semiconductor process chemicals company to expand its global footprint. Recent updates from 2025 highlight the launch of innovative products like Excalia Max (fungicide) and Lentigo (herbicide), which have seen encouraging adoption despite adverse weather conditions impacting the domestic crop protection business earlier in the year. Major institutional investors in the company include the Life Insurance Corporation of India (LIC), Plutus Wealth Management LLP, and several mutual funds such as HSBC Small Cap Fund and Aditya Birla Sun Life Flexi Cap Fund.